increase in adipocyte cell number (17) , but the development of hyperplasia is associated with the severe form of obesity and associated diseases (19) . Preadipocytes also contribute to the obesity-associated increase in circulating IL-6 (15) . In light of these observations, drugs for the control of preadipocyte proliferation may represent a novel approach to the treatment of obesity and associated diseases.
Ionic channels, e.g., K ϩ channels, play vital roles in regulating intracellular Ca 2ϩ concentration ([Ca 2ϩ ] i ) and subsequently cellular processes such as proliferation and differentiation in various cells. Especially in proliferative cells such as cultured vascular smooth muscle cells and cancer cells, ion channel activities largely participate in cell proliferation (26, 29, 31, 34, 40) . Preadipocytes are also a type of highly proliferating cell, and several studies have shown that K ϩ channels regulate cell proliferation (20, 30) . Hu et al. (20) showed that transient outward current (I to ) encoded by voltagedependent K ϩ channel (K V 4.2) and large-conductance Ca 2ϩ -activated K ϩ current (K Ca 1.1) participate in regulating proliferation of human preadipocytes. On the other hand, voltagegated Ca 2ϩ channels (Ca V ) are ubiquitously expressed in various cell types, and they also play roles in regulation of cellular functions including proliferation (26, 29) . So far, at least 10 genes that encode ␣-subunit of Ca V have been described (3) . The channels are classified in three broad families distinguished by the cell membrane potential at which they are active: Ca v 1 encoding high-voltage-activated (HVA) L-type Ca V ; Ca v 2 encoding HVA P/Q-type, N-type, and R-type Ca V ; and Ca v 3 encoding low-voltage-activated (LVA) T-type Ca V . In adipocytes, the existence of L-type Ca V has been shown by experimental and clinical studies. Gaur et al. (9, 10) reported that growth hormone regulates the distribution of L-type Ca V in rat adipocyte membrane and then basal levels of [Ca 2ϩ ] i . Nitrendipine, an L-type Ca 2ϩ channel blocker, enhances insulin sensitivity in obese and glucose-intolerant subjects (4) . In addition, LVA Ca 2ϩ channel was first described in 3T3 fibroblasts, with the use of patch-clamp techniques (5, 32) . Diaz-Velasquez et al. (8) showed the presence of ␣ 1G -subtype T-type Ca V in 3T3-F442A preadipocytes, a subclone of 3T3 Swiss mouse embryo fibroblasts (11, 12) , by using RT-PCR analysis and immunohistochemical studies. Recent studies have reported that mice lacking Ca v 3.1 T-type Ca V or mice treated with TTA-A2, a selective T-type Ca V blocker, are resistant to high-fat diet-induced weight gain and fat increase and exhibit improved body composition (39) . Additionally, TTA-A2 reduces body weight and fat mass of obese rodents (39) . Thus Ca V appear to provide a novel therapeutic target for the treatment of obesity. However, the molecular identities and physiological roles of Ca V expressed in preadipocytes remained unexplored.
Therefore, to clarify the characteristics of expression of Ca V in preadipocytes, whole cell voltage-clamp technique, conventional/ quantitative real-time RT-PCR, Western blot, small interfering RNA (siRNA) experiments, and immunohistochemical analysis were applied to mouse 3T3-L1 preadipocytes, a subclone of 3T3 Swiss mouse embryo fibroblasts (11, 12) , mouse primary cultured preadipocytes, and their differentiated adipocytes. Here we provide direct evidence that the Ca V 3.1 T-type Ca 2ϩ channel encoded by ␣ 1G subtype is the dominant Ca V in mouse preadipocytes and plays a role in the regulation of their proliferation. siRNA, small interfering RNA. Fig. 1 . Voltage-gated Ca 2ϩ currents (ICa) expressed in 3T3-L1 preadipocytes. A: cells were held at Ϫ100 mV, and command voltage pulses to ϩ0 mV (400 ms in duration) were applied. The bath solution contained 10 mM Ca 2ϩ in Aa and Ab. In Ac, 10 mM Ca 2ϩ was replaced by 10 mM Ba 2ϩ . Effects of TTX (10 M) and mibefradil (30 M) and nicardipine (1 M) are illustrated in Aa and Ab, respectively. Note that the transient inward current was blocked by mibefradil but not TTX and nicardipine. B: current voltage (I-V) relations measured at the peak of the transient inward current and the effects of holding potential (Vh). The current traces at various command voltage pulses were elicited from a Vh of Ϫ40 mV (Ba) or Ϫ100 mV (Bb). C: I-V relations measured at the peak. The transient inward current was elicited at a Vh of Ϫ100 mV, but not at Ϫ40 mV. D: steady-state activation (□) and inactivation (OE) curves for ICa. Data obtained from 4 cells were fitted by Boltzmann equation.
MATERIALS AND METHODS
The Animal Care and Use Committee of the University of Tokyo approved the present study.
Cell culture of 3T3-L1 preadipocytes and adipocyte differentiation method. 3T3-L1 preadipocytes were obtained from the Japanese Collection of Research Bioresources (JCRB) Bank (Osaka, Japan) as previously described (35) . Cells were maintained in Dulbecco's modified Eagle's medium (DMEM) supplemented with 10% fetal bovine serum (FBS) containing 100 g/ml penicillin and 100 g/ml streptomycin. Cells were plated and grown until 2 days after confluence and then induced to differentiate into adipocytes by change of the culture medium to DMEM containing 0.5 mM methylisobutylxanthine, 0.25 M dexamethasone, and 10 g/ml insulin for 48 h (36) . With this protocol, Ͼ95% of the cells were differentiated into the adipocyte phenotype 3-4 days after initiating differentiation. The differentiated 3T3-L1 adipocytes were switched to fresh DMEM containing 10% FBS.
Isolation and culture of preadipocytes and adipocytes from mouse white adipose tissue. Mouse primary cultured preadipocytes were obtained from Primary Cell (Hokkaido, Japan). The isolation method was similar to that in previous reports (1, 18) . Briefly, isolated epididymal white adipose tissue obtained from ICR mice at 2-4 days after birth was rinsed in collagenase solution. The mixture was then allowed to digest with gentle shaking. The resulting cell suspension was allowed to settle in order to separate into a supernatant containing adipocytes and an inferior layer composed mainly of preadipocytes. The primary cultured preadipocytes were used for later experiments. The preadipocytes were then seeded in a plate (2.4 ϫ 10 4 cells/plate) in DMEM supplemented with 10% fetal calf serum containing penicillin (10 U/ml), streptomycin (10 g/ml), (ϩ)-biotin (33 M), pantothenic acid (17 M), ascorbic acid (100 M), octanoic acid (1 M), and 3,5,3=-triiodothyronine (T3; 50 nM). The medium was replaced with differentiating medium consisting of the above medium with dexamethasone (2.5 M) and insulin (10 g/ml). Under these conditions, adipocyte differentiation occurred a few days later (7), and differentiated adipocytes were maintained in the differentiation medium without dexamethasone. Full differentiation developed at 8 -10 days after induction of differentiation.
Solutions and drugs. SNX-482, -agatoxin IVA, -conotoxin GVIA, diltiazem, and nicardipine) were obtained from Sigma. All experiments were performed at room temperature (20 -25°C) .
Recording technique and data analysis. Membrane currents were recorded with tight-seal whole cell clamp techniques and a patchclamp amplifier (EPC-7, List Electronics, Darmstadt, Germany) as previously described (14, 38) . Steady-state inactivation was estimated with a double-pulse protocol. Conditioning voltage pulses (500 ms in duration) of various membrane potentials were applied from a holding potential of Ϫ100 mV. At 10 ms after the end of each conditioning pulse, a test pulse of ϩ0 mV was applied. The ratio of I Ca amplitude with and without conditioning pulses was plotted against each conditioning voltage. From current-voltage (I-V) data, the steady-state activation curve was derived by using the following equation:
where ICa is the peak current amplitude at each membrane potential (Vm), gCa is the chord conductance, and ECa is the Ca 2ϩ equilibrium potential. ECa was obtained from the I-V curve, where the I-V curve crossed over the zero line.
RNA extraction, reverse transcriptase-polymerase chain reaction, and real-time quantitative reverse transcriptase-polymerase chain reaction. Total cellular RNA was extracted from preadipocytes and differentiated adipocytes with the RNeasy mini kit (Qiagen, Cambridge, MA). For reverse transcriptase-polymerase chain reaction (RT-PCR), complementary DNA (cDNA) was synthesized from 1 g of total RNA with reverse transcriptase and random primers (Toyobo, Osaka, Japan). The reaction mixture was then subjected to PCR amplification with specific forward and reverse oligonucleotide primers for 35 cycles consisting of heat denaturation, annealing, and extension. PCR products were size-fractionated on 2% agarose gels and visualized under UV light. Primers were chosen on the basis of the sequence of mouse ␣-subunit genes of Ca V (␣1A-␣1H) as shown in Table 1 . Table 1 also shows the CaV protein created by each gene. Total RNA of mouse adult brain was used for positive control. Real-time quantitative RT-PCR was performed with the use of realtime TaqMan technology and a sequence detector (ABI PRISM 7000, Applied Biosystems, Foster City, CA) (22) . Gene-specific primers and TaqMan probes were used to analyze transcript abundance. The 18S ribosomal RNA level was analyzed as an internal control and used to normalize the values for transcript abundance of Ca V family genes. The probes used in this study were purchased as Assay-on-Demand from Applied Biosystems: assay ID Mm00432190_ml for ␣ 1A, Mm00432226_ml for ␣ 1B, Mm00437917_ml for ␣1C, Mm00494444_ml for ␣ 1E, Mm01299131_ml for ␣1G, Mm00445369_ml for ␣1H, Mm01299033_ml for ␣ 1I, Mm01295675_ml for adipose protein 2 (aP2), Mm00494477_ml for Pref-1, and 4310893E for 18S rRNA endogenous control. We performed six independent experiments.
Oil Red O staining. Differentiated 3T3-L1 adipocytes were rinsed in PBS before being fixed with 10% formaldehyde. Approximately 15 min after the fixation, Oil Red O stain was used to stain for lipid accumulation (20 min). After being rinsed with distilled water, photomicrographs were taken with a digital camera to document staining.
Immunocytochemistry. Immunocytochemical analyses were performed on preadipocytes and differentiated adipocytes of 3T3-L1 and mouse primary cultured preadipocytes with anti-Ca V3.1 (Santa Cruz Biotechnology, Santa Cruz, CA), a rabbit polyclonal antibody against channel isoforms diluted to 1:100. The cells were cultured on Lab-Tek Chamber Slide Glass (Nalge Nunc International, Naperville, IL), fixed with 2% paraformaldehyde in PBS for 30 min, and then blocked for 10 min with 2% horse serum in PBS. The cells were incubated overnight with the primary antibodies diluted with 0.1% Triton X-100 and 0.01% NaN3 in PBS. For negative controls, cells were treated without antibody. Alexa Fluor 488-labeled donkey anti-rabbit IgG antibody diluted 1:1,000 (Molecular Probes, A21206) was used to visualize channel expression. The cells were also stained with Hoechst 33258 (Sigma Aldrich) to visualize nuclei. A confocal laser scanning microscope (Olympus FluoView FV300, Olympus, Tokyo, Japan) was used for observations.
Transfection of synthetic small interfering RNA. ␣1G siRNA and nonsilencing (negative control) siRNAs as described in Table 1 were purchased from Qiagen (Cambridge, MA). They were transfected into 3T3-L1 preadipocytes to a final concentration of 5 nM with Lipofectamine 2000 (5 l/ml culture; Invitrogen) according to the instructions of the manufacturer. Transfected cells were incubated for 48 h in an atmosphere of 5% CO2 and 95% air at 37°C before each experiment. Analysis of mRNA and protein by real-time RT-PCR and Western blot was then performed. Rhodamine-conjugated siRNA was used to confirm the transfection of siRNA with Nikon ECLIPSE TE2000-u. The density of ICa and the effects of siRNA on cell cycle were also investigated in the transfected cells.
Western blotting. Proteins were separated on a 7.5% polyacrylamide gel for 70 min at 200 V and then transferred to Amersham Hybond-P (GE Healthcare UK, Little Chalfont, UK) for 75 min at 72 mA. The membrane was blocked with 3% skim milk in PBS (0.01 M phosphate buffer, 0.138 M NaCl, 0.0027 M KCl, pH 7.4) with 0.1% Tween 20 (PBS-T) for 1 h. It was probed with anti-CaV3.1 polyclonal antibody diluted to 1:200 (Santa Cruz Biotechnology) and anti-␤-actin monoclonal antibody (1:10,000; Sigma) overnight at 4°C, washed three times in PBS-T for 15 min each, and subsequently incubated with anti-rabbit IgG linked to peroxidase (Millipore) diluted to 1:1,000 with blocking buffer for 1 h at room temperature. After three additional washes, bound antibodies were detected with Amersham ECL-plus (GE Healthcare UK) and analyzed with an LAS-3000 mini image analyzer (Fuji-Film, Tokyo, Japan).
Proliferation assay. Cell proliferation was assessed with the Cell Titer 96 Aqueous kit (Promega, Madison, WI). The preadipocytes were plated in 96-well plates (Becton Dickinson Labware, Franklin Lakes, NJ) at a density of 8 ϫ 10 4 cells/well with experimental media with or without Ca 2ϩ channel blockers. These plates were incubated for 24 h, after which the tetrazolium salt and dye solution were added and color development was allowed to proceed for 3 h at 37°C and 5% CO 2. Each plate was then read at an absorbance of 490 nm.
Flow cytometry. 3T3-L1 preadipocytes were plated at ϳ5,000 cells/cm 2 onto 10-cm plates and allowed to sit for 2 nights in FBS-free medium, and then cells were perfused into 5% FBS-containing medium in the presence or absence of Ca V blockers. In siRNA experiments, cells treated with ␣1G siRNA and nonsilencing (negative control) siRNAs were plated at ϳ5,000 cells/cm 2 onto 10-cm plates and allowed to sit for 24 h in FBS-free medium, and then cells were perfused into 5% FBS-containing medium. Cell cycle data were determined after 24-h treatment by flow cytometry in propidium iodide-stained mouse 3T3-L1 preadipocytes.
Data analysis. All values are expressed as means Ϯ SE. Differences between multiple groups were compared by ANOVA. Twogroup analysis was performed with a Student's t-test. Differences were considered significant if P Ͻ 0.05.
RESULTS
T-type Ca V in 3T3-L1 preadipocytes. Figure 1 , A-C, show I Ca expressed in 3T3-L1 preadipocytes where the bath solution contained 10 mM Ca 2ϩ . The cells were held at Ϫ100 mV, and command voltage pulses (400 ms in duration) were applied to ϩ0 mV. A fast transient inward current was elicited during the depolarizing pulse. TTX (10 M, Fig. 1Aa ) or replacement of extracellular Na ϩ with N-methyl-D-glucamine ϩ (data not shown), an impermeant cation, did not affect the transient inward current at all. However, mibefradil (30 M, Fig. 1Aa) , a potent inhibitor of T-and L-type currents (24), but not Fig. 5 . Comparison of CaV3.1 protein expression between preadipocytes and differentiated adipocytes. Western blot analysis shows the marked difference of CaV3.1 protein expression between 3T3-L1 preadipocytes and differentiated adipocytes (Aa) and between mouse primary cultured preadipocytes and differentiated adipocytes (Ba). In Ab and Bb, the relative abundance of CaV3.1 protein between preadipocytes and differentiated adipocytes is compared. The expression level of CaV3.1 protein was compared with that of ␤-actin, and the expression level in 3T3-L1 and mouse primary cultured preadipocytes is considered as 100%. Note that the expression level of CaV3.1 protein in differentiated adipocytes significantly decreased compared with 3T3-L1 preadipocytes and mouse primary cultured preadipocytes. **P Ͻ 0.01 vs. preadipocytes. nicardipine (1 M, Fig. 1Ab ), a potent L-type Ca 2ϩ channel blocker, completely abolished it. With replacement with 10 mM Ba 2ϩ instead of Ca 2ϩ , the amplitude of the inward current slightly decreased (Fig. 1Ac) . In addition, 1 M BAY K 8644 did not enhance it (data not shown), suggesting that highthreshold L-type Ca V or voltage-gated Na ϩ channels do not contribute to form the inward current expressed in 3T3-L1 preadipocytes but non-L-type Ca V do form it.
Typical current data recorded at each membrane potential and I-V relations measured at the peak of I Ca are shown in Fig.  1 , B and C. Cells were held at Ϫ40 mV (Fig. 1Ba) or Ϫ100 mV (Fig. 1Bb) in the same cell. When the cell was held at Ϫ100 mV, the transient inward currents were elicited at potentials more positive than Ϫ50 mV. The peak amplitude of I Ca was observed at approximately Ϫ20 mV and reached zero at potentials of approximately ϩ50 to ϩ60 mV. On the other hand, I Ca was not elicited during the depolarizing pulses at a holding potential of Ϫ40 mV. Figure 1D shows the steadystate inactivation curve for I Ca . The inactivation data were fitted to the following equation (Boltzmann equation) by using least-squares methods:
where V is the membrane potential in millivolts, V h is the membrane potential at half-maximum, and k is the slope factor. The values of V h and k were Ϫ51.7 Ϯ 0.9 mV and 8.4 Ϯ 0.8 (n ϭ 5), respectively. The steady-state activation curves were obtained from the conductance and also fitted by Boltzmann equation. The values of V h and k were Ϫ30.0 Ϯ 0.3 and Ϫ7.3 Ϯ 0.3 (n ϭ 5), respectively. The overlap of the steadystate activation and inactivation curves at potentials more positive than Ϫ50 mV determines the window currents. Figure 2 , A and B, shows the concentration-dependent effects of mibefradil on I Ca . Mibefradil inhibited I Ca with an IC 50 value of 3 M (Fig. 2B) , and mibefradil at concentrations Ͼ10 M nearly completely abolished I Ca . Next, we investigated the Ni 2ϩ sensitivity of I Ca (Fig. 2, C and D) . Ni 2ϩ concentrationdependently inhibited I Ca , with an IC 50 value of 200 M, and 1 mM Ni 2ϩ almost completely abolished it. Inhibitory effects were also observed with NNC55-0396 (10 M; Fig. 2E ), a selective inhibitor of T-type Ca V (21, 37) .
Furthermore, to determine which types of Ca V are involved in I Ca expressed in 3T3-L1 preadipocytes, we examined responses to a test stimulus applied in the absence or presence of various agents. The Ca 2ϩ channel blockers used here were as follows: mibefradil (10 M), NNC55-0396 (10 M), SNX-482 (a R-type Ca 2ϩ channel blocker; 100 nM), -agatoxin IVA (a P-type Ca 2ϩ channel blocker; 100 nM), -conotoxin GVIA (a N-type Ca 2ϩ channel blocker; 500 nM), and nicardipine (10 M). The percent inhibition of various Ca 2ϩ channel blockers is illustrated in Fig. 2F . Mibefradil and NNC55-0396 inhibited I Ca by 91 Ϯ 3% and 67.7 Ϯ 4.6%, respectively, but nicardipine inhibited it only by 3 Ϯ 1%. SNX-482, -agatoxin IVA, and -conotoxin GVIA were ineffective.
Dominant expression of Ca V 3.1 encoded by ␣ 1G mRNA in 3T3-L1 preadipocytes. We investigated the expression of ␣-subunit genes of Ca V family members (␣ 1A -␣ 1H mRNA). By RT-PCR analysis, the transcripts of ␣ 1A , ␣ 1B , ␣ 1C , ␣ 1E , ␣ 1G , and ␣ 1H were detected (Fig. 3A) and the transcripts of ␣ 1D and ␣ 1F were not detected compared with control mouse brain. The amplitude of cDNA fragments was of predicted molecular size, identical to cDNA fragments amplified from reversely transcripted mRNA. Expression of Ca V family members was also investigated by real-time quantitative RT-PCR (Fig. 3B) . Transcript levels were normalized to 18S ribosomal housekeeping gene. Thus ␣ 1G appeared to dominantly encode for ␣-subunit gene of Ca V in 3T3-L1 preadipocytes.
Expression of Ca V 3.1 protein was confirmed by immunostaining (Fig. 4Ab) and Western blots using anti-Ca V 3.1 (Fig. 5 , Aa and Ab) in 3T3-L1 preadipocytes. The cells were also counterstained with Hoechst 33258 to visualize nuclei, and the double staining of nucleus and Ca V 3.1 is shown in Fig. 4Ab . No expression was detected in negative controls without the antibody (Fig. 4Ac) .
We next investigated the effects of siRNA for ␣ 1G . Transfection of siRNA conjugated with rhodamine was confirmed by fluorescent microscopy (Fig. 4Ad) . After siRNA treatment the inhibitory effect on ␣ 1G mRNA expression was analyzed by real-time RT-PCR. The expression level of ␣ 1G mRNA in 3T3-L1 preadipocytes transfected with siRNA was significantly decreased compared with nonsilencing (negative control) siRNA ( Fig. 6A ; P Ͻ 0.01, n ϭ 6). Western blot analysis showed that the protein expression level of Ca V 3.1 in 3T3-L1 preadipocytes transfected with siRNA was also decreased compared with nonsilencing (negative control) siRNA (P Ͻ 0.01, n ϭ 3; Fig. 6 , Ba and Bb). Next, I Ca was recorded with tight-seal whole cell clamp techniques in the transfected cells (20 cells, siRNA for ␣ 1G and negative control, respectively). The current density of I Ca adjusted by cell capacitance was significantly reduced in cells transfected with siRNA for ␣ 1G ( Fig. 6C ; P Ͻ 0.01), compared with nonsilencing (negative control) siRNA.
Ca V in mouse primary cultured preadipocytes. Expression of ␣-subunit genes of Ca V family members (␣ 1A -␣ 1I ) was also investigated by real-time quantitative RT-PCR (Fig. 3C ) in mouse primary cultured preadipocytes, and ␣ 1G appeared to encode for ␣-subunit gene of Ca V in a similar way to that in mouse 3T3-L1 preadipocytes. Expression of Ca V protein was confirmed by immunostaining (Fig. 4Ba) and Western blot analysis using anti-Ca V 3.1 (Fig. 5, Ba and Bb) , which was similar to 3T3-L1 preadipocytes. The cells were also counterstained with Hoechst 33258 to visualize nuclei, and the double staining of nucleus and Ca V 3.1 is shown in Fig. 4Ba .
Comparison of ␣ 1G mRNA expression between preadipocytes and differentiated adipocytes. We examined the effects of differentiation on ␣ 1G mRNA expression in both 3T-L1 preadipocytes and mouse primary cultured preadipocytes. After differentiation, lipid accumulation stained by Oil Red O stain could be observed in 3T3-L1 cells (Fig. 4Ae) . Similarly, lipid accumulation was observed in differentiated mouse adipocytes (Fig. 4Bb) . Figure 7 compares the expression levels of ␣ 1G and aP2 mRNA, a differentiated marker gene of adipocyte, in both cell types. The expression level of aP2 mRNA was notably increased in 3T3-L1 adipocytes and mouse adipocytes, while the expression level of ␣ 1G mRNA was significantly decreased during the differentiation. In addition, the mRNA expression level of Pref-1 (also known as DLK-1), a marker of preadipocytes, was significantly high in both preadipocytes (Fig. 7) . Similarly, Western blot analyses showed that the protein expression level of Ca V 3.1 in adipocytes was significantly decreased compared with 3T3-L1 preadipocytes (P Ͻ 0.01, n ϭ 4; Fig. 5 , Aa and Ab) and mouse preadipocytes (P Ͻ 0.01, n ϭ Fig. 8 . Effects of Ca 2ϩ channel blockers on cell proliferation and cell cycle in 3T3-L1 preadipocytes. Aa and Ab: effects of diltiazem, nicardipine, and mibefradil (10 M; Aa), and NNC55-0396 (1-10 M; Ab) on cell proliferation. Note that cell proliferation was significantly inhibited by mibefradil and NNC55-0396, but not diltiazem and nicardipine. Data were obtained from 5-7 experiments. *P Ͻ 0.05 vs. control. B and C: effects of NNC55-0396 and diltiazem on cell cycle analyzed by flow cytometry. Serum-deprived cells were again treated with 5% FBS culture medium in the absence or presence of these drugs for 24 h and analyzed by flow cytometry. Representative data obtained from 3 experiments are shown in the absence and presence of NNC55-039 (10 M; B) and diltiazem (10 M; C). D: summary data showing % of cells in G0/G1, S, and G2/M. Groups: 5% FBS (control), 5% FBS with NNC55-0396 10 M, 5% FBS with 10 M diltiazem. Treatment with NNC55-0396 showed a much smaller proportion of cells entering S and G2/M and a much higher proportion arrested in G0/G1, while diltiazem did not mimic the effects of NNC55-0396. **P Ͻ 0.01. 4 ; Fig. 5 , Ba and Bb). Immunohistochemical staining using anti-Ca V 3.1 showed the expression of ␣ 1G in both differentiated 3T3-L1 adipocytes (Fig. 4Af) and mouse differentiated adipocytes (Fig. 4Bc ), but compared with preadipocytes, weak staining or no staining was observed in both differentiated adipocytes.
T-type Ca V blockers and siRNA for ␣ 1G mRNA inhibit cell proliferation in 3T3-L1 preadipocytes. Figure 8 shows the effects of various Ca 2ϩ channel blockers on cell proliferation and cell cycle in 3T3-L1 preadipocytes. Mibefradil (10 M; Fig. 8Aa ) and NNC55-0396 (1-10 M; Fig. 8Ab ) significantly inhibited cell proliferation in response to FBS, while diltiazem and nicardipine (10 M; Fig. 8Aa ) had little effect. In addition, we investigated the effects of NNC55-0396 (Fig. 8B) and diltiazem (Fig. 8C) on cell cycle. Cells were treated in the absence or presence of these drugs for 24 h and analyzed by flow cytometry. Treatment with NNC55-0396 (10 M; Fig. 8,  B and D) showed a smaller proportion of cells entering S and G 2 /M and a higher proportion arrested in G 0 /G 1 , while diltiazem [10 M (Fig. 8, C and D) and 30 M (data not shown)] did not mimic the effects of NNC55-0396. The effects of siRNA targeted for ␣ 1G mRNA on cell proliferation and cell cycle in the response to serum were also investigated. As shown in Fig. 9A , siRNA targeted for ␣ 1G mRNA significantly inhibited cell proliferation in response to FBS compared with control siRNA. In addition, compared with nonsilencing (negative control) siRNA-treated cells (Fig. 9 , Bb and C), cells treated with siRNA targeted for ␣ 1G mRNA showed a much smaller proportion of cells entering G 2 /M and a much higher proportion arrested in G 0 /G 1 in the presence of FBS (Fig. 9 , Ba and C). On the other hand, siRNA did not affect the cell cycle in the absence of FBS (data not shown). Thus it is likely that siRNA targeted for ␣ 1G mRNA inhibited cell cycle entry/ progression, but not because of toxic effects.
DISCUSSION
The major findings of the present study are as follows. 1) T-type Ca 2ϩ channel encoded by ␣ 1G subtype, blocked by mibefradil, Ni 2ϩ , NNC55-0396, and siRNA for ␣ 1G , was the dominant Ca V in mouse 3T3-L1 preadipocytes. 2) RT-PCR, Western blot, and immunohistochemical analysis also showed the dominant expression of Ca V 3.1 T-type Ca V in mouse primary cultured preadipocytes as well as 3T3-L1 preadipocytes.
3) The expression level of Ca V 3.1 encoded by ␣ 1G was significantly downregulated in differentiated adipocytes by decreasing the transcription level. 4) Mibefradil, NNC55-0396, but not diltiazem, and siRNA for ␣ 1G inhibited cell proliferation in response to serum. NNC55-0396 and siRNA for ␣ 1G inhibited cell cycle entry/progression. These results demonstrate for the first time that the T-type Ca 2ϩ channel encoded by ␣ 1G subtype is the dominant Ca V in mouse preadipocytes and plays a role in the regulation of their proliferation.
Ca V are ubiquitously expressed in various cell types and play vital roles in regulation of cellular functions such as proliferation. The existence of Ca V has also been described in preadipocytes and adipocytes (4, 5, 10, 32) , but the molecular identities and function of Ca V remained quite unexplored. Recently, Diaz-Velasquez et al. (8) showed the presence of ␣ 1G -subtype T-type Ca V in 3T3-F442A preadipocytes, a subclone of 3T3 Swiss mouse embryo fibroblasts (11, 12) , by using RT-PCR analysis and immunohistochemical studies. The present study showed the presence of Ca V in mouse 3T3-L1 preadipocytes by using patch-clamp experiments. Mibefradil, a T-and L-type Ca 2ϩ channel blocker (24) , inhibited it with an IC 50 value of 3 M, and NNC55-0396, a selective T-type Ca 2ϩ channel blocker (21, 37) , also inhibited it. Also, the other Ca 2ϩ channel blockers, SNX-482, -agatoxin IVA, -conotoxin GVIA, and nicardipine, were less or only a little effective to inhibit Ca V , compared with mibefradil or NNC55-0396. Ni 2ϩ inhibited it with an IC 50 value of 200 M. In a heterologous expression system, the ␣ 1H subtype has been reported to exhibit a greater sensitivity to inhibition by NiCl 2 (IC 50 ϳ10 M) than either the ␣ 1G or ␣ 1I subtype (IC 50 ϳ200 -300 M) (23, 27 The present study also provides the first evidence showing the expression of Ca V transcripts in mouse primary cultured preadipocytes as well as 3T3-L1 preadipocytes. The dominant expression of ␣ 1G mRNA was detected by conventional/quantitative real-time RT-PCR among Ca V transcripts (␣ 1A -␣ 1I ), and the expression of Ca V 3.1 protein encoded by ␣ 1G gene was detected by immunohistochemical studies and Western blot analysis in both mouse preadipocytes. In addition, the protein level of Ca v 3.1 encoded by ␣ 1G mRNA was significantly downregulated in differentiated adipocytes by decreasing the transcription level. Thus T-type Ca 2ϩ channel encoded by ␣ 1G subtype does not appear to function in mature white adipocytes, but alternatively it seems to play a vital role in the function of mouse preadipocytes. However, in contrast with the data of immunohistochemical studies and Western blot analysis, we have not been able to detect the obvious T-type Ca V by patch-clamp experiments. Probably T-type Ca V in mouse primary cultured preadipocytes may be very small for detection. Alternatively, it may be quickly decreased or run down under the culture conditions. Therefore, further studies using freshly isolated preadipocytes are needed to clarify the existence of T-type Ca V in mouse preadipocytes.
Diaz-Velasquez et al. (8) reported that T-type Ca V may be involved in adipocyte differentiation, where mibefradil and Ni 2ϩ partially inhibited staurosporine-induced preadipocyte conversion to adipocytes. They proposed that Ca 2ϩ mobilization by at least T-type Ca V is involved in adipocyte differentiation, where GSK3␤ activation depends on transient increase in [Ca 2ϩ ] i (13, 16) . Proliferation of preadipocytes is also an important key step in adipose tissue development since it conditions the number of potential new adipocytes in the adipose tissue. Electrophysiological studies have shown the expression of K ϩ channels in isolated cultured brown fat cells from neonatal rats and human preadipocytes, which may control membrane potential and then cellular proliferation and differentiation of preadipocytes. Hu et al. (20) reported that K ϩ channel blockers inhibited human preadipocyte proliferation by accumulating cells at G 0 /G 1 and reducing S-phase population. In the present study, we showed that mibefradil inhibited 3T3-L1 proliferation in response to serum, while diltiazem and nicardipine were less effective. We also investigated the effects of NNC55-0396, a selective T-type Ca 2ϩ channel blocker (21, 37), on cell proliferation and cell cycle. NNC55-0396 inhibited T-type Ca V expressed in 3T3-L1 preadipocytes and significantly suppressed cell proliferation, by inhibiting cell cycle entry with accumulating cells at G 0 /G 1 and reducing S-and G 2 /M-phase population. Similarly, siRNA targeted for ␣ 1G inhibited cell proliferation and reduced G 0 /G 1 -phase population in response to serum. However, siRNA also appears to inhibit progression of S phase into G 2 /M phase. The reason for the difference between NNC55-0396 and siRNA remains unclear, but the additional, nonspecific action of NNC55-0396 or the toxic effects of siRNA cannot be ruled out in this study. Further studies are needed to clarify the involvement of T-type Ca V in the cell cycle. However, the present study showed that T-type Ca V encoded by ␣ 1G subtype appears to play a role in the regulation of cell cycle entry/progression, and subsequently cell proliferation, in mouse preadipocytes. T-type Ca 2ϩ channels may play a vital role in proliferation when activated by transient membrane depolarization or when they are open at resting membrane potentials as judged from window current, thereby promoting a steady-state calcium entry. Consistent with a role for Ca V 3.1 in controlling the cell cycle, similar effects on proliferation have been reported in cultured human pulmonary arterial cells and also in nonexcitable cells such as tumor cells (28, 34) . Thus it is very likely that T-type Ca 2ϩ channels play a role in regulating [Ca 2ϩ ] i , and subsequently preadipocyte proliferation.
Recent in vivo studies have shown that mice lacking Ca v 3.1 T-type Ca V or mice treated with TTA-A2, a selective T-type Ca V blockade, are resistant to high-fat diet-induced weight gain and fat increase and exhibit improved body composition (39) . These effects likely result from better alignment of diurnal feeding patterns with daily changes in circadian physiology, although the involvement of T-type Ca V on adipose tissues has not been investigated. The present study showed that the T-type Ca 2ϩ channel plays a role in the regulation of cell proliferation in mouse preadipocytes. Thus T-type Ca 2ϩ channel blockers appear to be interesting new drugs for obesity.
In conclusion, the present study demonstrates that the T-type Ca 2ϩ channel encoded by ␣ 1G subtype is the dominant Ca V in mouse preadipocytes and plays a role in the regulation of their proliferation, a key step in adipose tissue development.
